1-4 of 4
Fred E. Bertrand
Close
Sort by
Journal Articles

HoxA9 Induces Insulin-Like Growth Factor-1 Receptor (IGF-1R) Expression in Acute Leukemia.

Jarrett T. Whelan, BS, Dale L. Ludwig, Ph.D., Fred E. Bertrand, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3343.
https://doi.org/10.1182/blood.V110.11.3343.3343
Published: 2007
Journal Articles

Role of BRAF Mutations in Hematopoietic Malignancies and the Induction of Cytokine-Independence-Synergy with PI3K/Akt Pathway.

Massimo Libra, MD, Maria C. Mazzarino, MD, Valli De Re, PhD, Linda S. Steelman, MS, Steven L. Abrams, BS, Fred E. Bertrand, PhD, John G. Shelton, PhD, Sarah Molton, PhD, Martin McMahon, PhD, James A. McCubrey, PhD
Journal: Blood
Blood (2005) 106 (11): 4291.
https://doi.org/10.1182/blood.V106.11.4291.4291
Published: 2005
Journal Articles

Key Roles of the Raf-1 and Akt in Drug Resistance, Cell Cycle Progression and the Prevention of Apoptosis in Hematopoietic Cells.

Steven L. Abrams, BS, Linda S. Steelman, MS, John G. Shelton, PhD, William H. Chappell, MS, Ellis W.T. Wong, BS, Fred E. Bertrand, PhD, James A. McCubrey, PhD
Journal: Blood
Blood (2005) 106 (11): 1356.
https://doi.org/10.1182/blood.V106.11.1356.1356
Published: 2005
Journal Articles

Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein

Fred E. Bertrand, Christine Vogtenhuber, Nisha Shah, Tucker W. LeBien
Journal: Blood
Blood (2001) 98 (12): 3398–3405.
https://doi.org/10.1182/blood.V98.12.3398
Published: 2001